Quick answerBlock
eluxadoline exposure after cholecystectomy.
Why this is correctThe safety screen occurs before the first dose. Waiting for symptoms exposes the client to a known contraindication.
Easy analogy or mental pictureUse a closed medication-safety loop: identify the exposure, connect the new findings, interrupt further harm, support physiology, and verify the response over time.
Memory hookExposure, interaction, toxicity pattern, immediate action, serial reassessment.NCLEX decision ruleChoose the action that reduces the most immediate medication-related risk while preserving monitoring and escalation.
Why the other choices are wrongOptions that continue the exposure, treat only one symptom, or delay reassessment leave the toxic process active.
References
1DailyMed: VIBERZI (eluxadoline)Contraindication without a gallbladder and risk of pancreatitis or sphincter of Oddi spasm